EMVision Medical Devices Ltd

ASX:EMV Stock Report

Market Cap: AU$219.5m

EMVision Medical Devices Past Earnings Performance

Past criteria checks 0/6

EMVision Medical Devices's earnings have been declining at an average annual rate of -9%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 40.8% per year.

Key information

-9.0%

Earnings growth rate

1.1%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate40.8%
Return on equity-56.5%
Net Margin-37.2%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Is EMVision Medical Devices (ASX:EMV) A Risky Investment?

Nov 21
Is EMVision Medical Devices (ASX:EMV) A Risky Investment?

Here's Why We're Not At All Concerned With EMVision Medical Devices' (ASX:EMV) Cash Burn Situation

Apr 24
Here's Why We're Not At All Concerned With EMVision Medical Devices' (ASX:EMV) Cash Burn Situation

EMVision Medical Devices Ltd's (ASX:EMV) CEO Compensation Is Looking A Bit Stretched At The Moment

Nov 09
EMVision Medical Devices Ltd's (ASX:EMV) CEO Compensation Is Looking A Bit Stretched At The Moment

We're Not Very Worried About EMVision Medical Devices' (ASX:EMV) Cash Burn Rate

Oct 04
We're Not Very Worried About EMVision Medical Devices' (ASX:EMV) Cash Burn Rate

Companies Like EMvision Medical Devices (ASX:EMV) Are In A Position To Invest In Growth

Jun 17
Companies Like EMvision Medical Devices (ASX:EMV) Are In A Position To Invest In Growth

We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

Jan 07
We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

Oct 04
We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

Jun 08
We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

Here's Why We're Not Too Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Situation

Feb 22
Here's Why We're Not Too Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Situation

Investors Who Bought EMvision Medical Devices (ASX:EMV) Shares A Year Ago Are Now Up 319%

Dec 20
Investors Who Bought EMvision Medical Devices (ASX:EMV) Shares A Year Ago Are Now Up 319%

We Think EMvision Medical Devices (ASX:EMV) Can Afford To Drive Business Growth

Nov 24
We Think EMvision Medical Devices (ASX:EMV) Can Afford To Drive Business Growth

Revenue & Expenses Breakdown
Beta

How EMVision Medical Devices makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:EMV Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 239-383
30 Sep 238-483
30 Jun 237-482
31 Mar 236-482
31 Dec 226-582
30 Sep 225-582
30 Jun 224-682
31 Mar 224-782
31 Dec 213-782
30 Sep 213-882
30 Jun 212-873
31 Mar 212-763
31 Dec 202-543
30 Sep 202-433
30 Jun 202-323
31 Mar 202-323
31 Dec 192-323
30 Sep 192-322
30 Jun 191-322
31 Mar 191-322
31 Dec 181-222
30 Sep 181-211
30 Jun 180-101
30 Apr 181001

Quality Earnings: EMV is currently unprofitable.

Growing Profit Margin: EMV is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: EMV is unprofitable, and losses have increased over the past 5 years at a rate of 9% per year.

Accelerating Growth: Unable to compare EMV's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EMV is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: EMV has a negative Return on Equity (-56.47%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.